Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Hydrocortisone

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

54 API Suppliers, 29 USDMF, 13 CEP/COS, 6 JDMF, 5 EU WC, 10 KDMF, 41 NDC API, 1 VMF, 28 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

21 Drugs in Development

21 Drugs in Development

FINISHED DOSAGE FORMULATIONS

387 FDF Dossiers, 230 FDA Orange Book, 83 Europe, 14 Canada, 8 Australia, 27 South Africa, 25 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION/DROPS;OTIC - EQ 0.2% BASE;1%, CREAM;TOPICAL - 5%;1%, OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 1%, TABLET;ORAL - 10MG, TABLET;ORAL - 20MG, TABLET;ORAL - 5MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 5 Rochem International Inc, 8 SPI Pharma, 17 DKSH, 1 Pharm-RX Chemical, 7 Faran Shimi Pharmaceutical, 6 Gangwal Healthcare, 24 Nanjing Well Pharmaceutical, 5 Pfanstiehl, 22 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 42 BASF, 3 BioSpectra, 1 Clariant, 15 Corel Pharma Chem, 7 DFE Pharma, 6 Finar, 16 Gangwal Chemicals, 2 Hayashibara, 3 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 31 Kerry, 9 Lubrizol Life Science Health, 17 Microlex e.U, 3 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 33 Roquette, 21 Seppic, 2 Shandong Focus Biotechnology Co., Ltd, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 2 Valens Pharmachem, 5 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

89 Topical, 73 Fillers, Diluents & Binders, 57 Solubilizers, 57 Thickeners and Stabilizers, 43 Parenteral, 31 Direct Compression, 30 Coating Systems & Additives, 28 Granulation, 28 Lubricants & Glidants, 27 Disintegrants & Superdisintegrants, 27 Emulsifying Agents, 23 Controlled & Modified Release, 20 Film Formers & Plasticizers, 20 Surfactant & Foaming Agents, 18 Taste Masking, 16 Co-Processed Excipients, 11 Chewable & Orodispersible Aids, 9 Rheology Modifiers, 5 API Stability Enhancers, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 47 News #PharmaBuzz

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 91 Regulatory FDF Prices, 1 Annual Reports

MARKET PLACE

33 APIs, 17 FDF Dossiers

PATENTS & EXCLUSIVITIES

12 US Patents

12 US Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 4 USP, 3 JP, 5 Others

ANALYTICAL

2 BioAnalytical Methods, 4 Analytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Labeler	NDC Package Code	Non Proprietary Name	Start Marketing Date	End Marketing Date	Category Code	Dosage Form (Strength)
28/03/2025	Symbiotec Pharmalab	India	Symbiotec Pharmalab Private Limited	22552-0037	HYDROCORTISONE	2013-06-04	2025-12-31	BULK INGREDIENT	POWDER (1g/g)
28/03/2025	Axplora	Germany	Farmabios S.p.A.	46439-8778	HYDROCORTISONE HEMISUCCINATE	2025-01-14	2026-12-31	BULK INGREDIENT	POWDER (1g/g)

Hydrocortisone

Hydrocortisone

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

54 API Suppliers

29 USDMF

13 CEP/COS

6 JDMF

5 EU WC

10 KDMF

41 NDC API

1 VMF

28 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

21 Drugs in Development

FINISHED DOSAGE FORMULATIONS

387 FDF Dossiers

230 FDA Orange Book

83 Europe

14 Canada

8 Australia

27 South Africa

25 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION/DROPS;OTIC - EQ 0.2% BASE;1%

CREAM;TOPICAL - 5%;1%

OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - 1%

TABLET;ORAL - 10MG

TABLET;ORAL - 20MG

TABLET;ORAL - 5MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI

5 Rochem International Inc

8 SPI Pharma

17 DKSH

1 Pharm-RX Chemical

7 Faran Shimi Pharmaceutical

6 Gangwal Healthcare

24 Nanjing Well Pharmaceutical

5 Pfanstiehl

22 Actylis

1 Aeon Procare

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

42 BASF

3 BioSpectra

1 Clariant

15 Corel Pharma Chem

7 DFE Pharma

6 Finar

16 Gangwal Chemicals

2 Hayashibara

3 Ideal Cures Pvt Ltd

4 Ingredion Pharma Solutions

31 Kerry

9 Lubrizol Life Science Health

17 Microlex e.U

3 Nanjing Bold Chemical

2 Nippon Fine Chemical

2 Nomisma Healthcare

1 Novo Excipients

2 Pharmatrans-Sanaq

8 Pluviaendo

4 Prachin Chemical

33 Roquette

21 Seppic

2 Shandong Focus Biotechnology Co., Ltd

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

11 Sigachi Industries

2 Valens Pharmachem

5 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

89 Topical

73 Fillers, Diluents & Binders

OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons